As the cell and gene therapy industry rapidly expands, developers face mounting pressure to scale efficiently while navigating complex regulatory and manufacturing landscapes. This article explores the strategies top innovators use to streamline development, reduce costs, and accelerate timelines—without compromising quality or compliance.
Based on insights from experts at Charles River Laboratories, it highlights the importance of early-stage planning, smart automation, and iterative feedback loops. Whether you're preparing for IND filing or planning long-term commercial success, this piece offers a practical look at what sets successful programs apart
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.